Antipodes Partners, a leading global equity boutique, has made a series of investment team and management appointments as the group’s growth continues to accelerate.
Antipodes Partners continues to witness strong investor demand – both institutional and retail – for its long/short and long-only global equity strategies, taking its AUM to approximately GBP4bn more than three years on from its inception.
Coinciding with the growth in investor demand, Antipodes Partners has also made a number of hires across its Sydney office and recently-established London office.
Andrew Findlay has been appointed managing director of Antipodes Partners, overseeing the group’s business activities. Findlay was previously a senior executive at Pinnacle Investment Management – a minority owner and the distribution partner of Antipodes Partners.
Aidan Kerr has been appointed as an investment analyst, covering the global healthcare sector. Previously, Kerr was an equity analyst in the healthcare team at Magellan Financial Group. Has also worked for AstraZeneca, Accenture and as a research scientist at the University of New South Wales.
Ben Turner has been appointed to manage Antipodes Partners’ dealing function in London. Ben joins Antipodes Partners from Adelphi Capital where he was responsible for investment analysis, risk management and trading. Prior to Adelphi, Ben worked for UBS as a member of the bank’s highly ranked hedge fund business.
Vinayak Muralidharan has been appointed as an investment analyst, covering the global financials and infrastructure sectors. Before joining Antipodes Partners, Muralidharan spent seven years with Magellan Financial Group as an equities analyst, focused on global banks and diversified financials.
Kieran Rabbitt has been appointed as investment specialist, responsible for portfolio analytics and systems development – expanding Antipodes Partners’ quant/macro team to four. He previously spent eight years at Dimensional Fund Advisors.
Jacob Mitchell (pictured), founder and chief investment officer of Antipodes Partners, says: “Andrew has been instrumental to Antipodes’ success since day one and I am pleased he has taken on the role of managing director. Based on my experience, it is best to separate the functions of investing and business management. Antipodes is a performance-driven firm and my time is best spent leading our growing investment team.
“We are also extremely pleased with the calibre of our recent hires within our now 19-strong investment team, of which three of the professionals are now based in London. With our investment-led culture, we have become an employer of choice for talented professionals who want to further their career in global equity investing.”
In addition to the internal hires at Antipodes Partners, Nick Keem and Ben Cossey have been appointed as distribution directors at Pinnacle Investment Management. Keem joins Pinnacle from JPMorgan Asset Management, where he was head of wealth managers. He has also worked for F&C Alternative Investments, Threadneedle Investment Managers and Gartmore Investment Management. Cossey joins Pinnacle from Stable Asset Management, while he also had roles at UBS Wealth Management and LaSalle Investment Management. Keem and Cossey will support the growing demand for Antipodes Partners proposition in the UK, Continental Europe and the US.
Mitchell adds: “Over the past three years our global network of clients has grown exponentially. Expanding locally into new markets is a natural progression for the business. Accordingly, we are pleased Ben and Nick will be extending the relationships we already have in these key markets and introducing our recently-launched UCITS global equity strategies to a wider global audience.”
These hires follow the opening of Antipodes Partners’ London office in September 2017 and the launch of two UCITS funds for UK and European investors: the Antipodes Global Fund – Long Only and the Antipodes Global Fund, a long biased long/short fund.
